Company: DNLI
Filing Date: 2025-02-27
Form Type: 8-K
Source: 0001714899-25-000067
Chunk: 4

Company: Denali Therapeutics Inc.
Filing Date: 2025-02-27
Form: 8-K
Item: Item 9.01
Chunk 4
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                                                                          
          1.1      Equity Distribution Agreement, dated February 27, 2025 between the Registrant and Goldman Sachs & Co. LLC and Leerink Partners LLC.  
         99.1      Press Release dated February 27, 2025.                                                                                               
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (formatted as Inline XBRL)                                                                          

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                    DENALI THERAPEUTICS INC.                                             
  Date:      February 27, 2025      By:                           /s/ Alexander O. Schuth                
                                                                  Alexander O. Schuth, M. D.             
                                                                  Chief Operating and Financial Officer